DEEPVESSEL PLAQUE
Quantitative plaque analysis from CCTA. See the complete picture. Request a demoDownload DVPlaque Product Sheet
FDA-cleared, AI-assisted analysis of coronary plaque and stenosis from CCTA, delivering quantitative measurements and visual reports for clinical review.
See more than luminal narrowing.
CCTA reveals more than the presence of stenosis. DEEPVESSEL Plaque helps qualified clinicians assess the presence and extent of coronary atherosclerosis through quantitative plaque measurements, stenosis categorization, and visual clinical reports.
- Total plaque volume
- Non-calcified plaque volume
- Plaque burden
- Calcified plaque volume
- Low-density plaque volume
- CAD-RADS stenosis category
Quantitative findings. Visual context.
CCTA reveals more than the presence of stenosis. DEEPVESSEL Plaque helps qualified clinicians assess the presence and extent of coronary atherosclerosis through quantitative plaque measurements, stenosis categorization, and visual clinical reports.
CardiSight Overview Report
A visual overview of coronary anatomy, plaque location, and CAD-RADS stenosis category.
Plaque Analysis Report
Detailed vessel- and patient-level plaque volumes, burden, composition, and stenosis assessment.
AI-assisted analysis with trained analyst review.
Secure image transfer
Analysis and review
Clinical reports delivered
COMPOSE-CT Study
A retrospective, multicenter study evaluated 147 CCTA datasets from three independent U.S. clinical sites. Performance was compared with consensus established by three expert readers.
0.976
Total plaque volume
Pearson correlation
0.810
CAD-RADS category
Weighted kappa
0.994
Calcified plaque volume
Pearson correlation
23
Cases in separate
Repeatability & Reproducibility evaluation
Comprehensive CCTA
Complementary insights. Separate clearances.
Ready to see what DEEPVESSEL Plaque can deliver?
For healthcare professionals in the United States